Hep C Virus - Peregrine advances hepatitis C drug

Peregrine advances hepatitis C drug
Pharmaceutical Business Review - Feb 17, 2006... The single dose ascending trial was conducted in patients with chronic hepatitis C virus (HCV) who have either failed or no longer respond to standard of care ...

Seronons 2005 Adjusted(i) EPS Increased by 34.6%
MSN Money - Feb 5, 2006... outcome of the combination phase of a study evaluating the effect of interferon-beta-1a with ribavirin for the treatment of chronic hepatitis C (HCV) in Asian ...

Vertex Successfully Completes Key Studies with VX-950 to Prepare ...
Canada NewsWire (press release), Canada - Feb 6, 2006-- Plasma HCV RNA levels are ... Clinical Study Design and Results The 28-day, Phase II clinical study enrolled 12 treatment-naive patients with genotype 1 HCV. ...

Transgene: 2005, A Year of Significant Achievements Paving the Way ...
PharmaLive.com (press release), PA - Feb 22, 2006... Preparation on track for the Phase I/II study with TG 4040 (MVA-HCV) in patients chronically infected by the hepatitis C virus. ...